UBS Knock-Out ABT/ DE000UK78T65 /
5/17/2024 7:25:34 PM | Chg.-0.060 | Bid7:25:34 PM | Ask7:25:34 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.710EUR | -1.26% | 4.710 Bid Size: 25,000 |
4.720 Ask Size: 25,000 |
Abbott Laboratories | 53.7874 USD | 12/31/2078 | Call |
GlobeNewswire
5/9
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors